Reneo Pharmaceuticals

IPO

Reneo Pharmaceuticals is a biotech company in San Diego, United States, founded in 2014. It has raised $210.0M across 3 rounds, most recently a $65.0M Venture Round in October 2024.

Employees
11–50
Founded
2014
Business Model
B2B
Total Funding
$210.0M
Last Round
$65.0M Venture RoundOct 2024
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 9 investors for this company. The full record is or through the API.

About

Reneo Pharmaceuticals was a clinical-stage biopharmaceutical company founded in 2014 in San Diego, California, focused on the development of therapies for patients with rare genetic mitochondrial diseases. Reneo's lead program, REN001 (a PPARdelta agonist), targeted primary mitochondrial myopathy. The company went public on Nasdaq in April 2021 under the symbol RPHM. Following a Phase 2b clinical trial failure in May 2024, Reneo merged with OnKure Therapeutics, closing the merger in October 2024.

Summary

It lists 11–50 employees. It has raised $210.0M in total across 3 rounds, most recently a $65.0M Venture Round in Oct 2024. Investors include Abingworth Bioventures, Novo Holdings A/S and New Enterprise Associates.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Venture RoundConcurrent Private PlacementOct 2024
$65.0M

Sign up to see all 7 events

Funding: Series A through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Reneo Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/reneo-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/reneo-pharmaceuticals" alt="Reneo Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>